Randomized, phase 3, double-blind, placebo-controlled study of pazopanib with or without abexinostat in patients with locally advanced or metastatic renal cell carcinoma
2018-001495-38Carcinoma de células renalesFundación Jiménez DíazInvestigador: Rubio Romero Gustavo